Post-renal Transplant Retzius Sparing Robotic Radical Prostatectomy: Initial Experience and Case Report

Abstract

Retzius sparing robotic radical prostatectomy is now an accepted alternative to standard RARP. Our paper aims to evaluate the feasibility, complications, and oncological outcomes of the RS-RARP in kidney transplant recipients. We did a retrospective analysis of 3 patients who underwent retzius sparing robotic radical prostatectomy post-renal transplant. Operative, oncological, and functional outcomes are analyzed. A total of 3 patients underwent RS-RARP post-renal transplant. Mean operative time was 143.2 ± 9.06 min, and nerve-sparing was performed on one side in 1 patient. None of the patients had any intraoperative or postoperative events. Final pathological staging was upgraded in all three patients and was pT3aN0Mx. All three patients were fully continent in the immediate postoperative period after catheter removal. All three patients were free of biochemical recurrence with PSA of less than 0.2 in all patients with no need for additional treatment till last follow-up. There was no change in renal function in the immediate postoperative period and 1 month follow-up in any patient. Retzius sparing robotic radical prostatectomy can be performed safely in a post-transplant setting with minimal complications and excellent functional and oncological outcomes.